Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Nicholas

Showing results (61-70 of 165) with videos related to

Pageof 17
Sort By:
Neurology|September 19, 2018
The utility of FDG-PET imaging in distinguishing PML-IRIS from PML in a patient treated with natalizumabAravindhan Baheerathan, Cillian McNamara, Sabrina Kalam, et al.
Orthopedics|October 3, 2014
Diabetic myonecrosis: likely an underrecognized entityMathew J Mazoch, Gitanjali Bajaj, Richard Nicholas, et al.
Pediatric Blood & Cancer|June 29, 2019
Effect of sirolimus on coagulopathy of slow-flow vascular malformationsJoana M Mack, Bethany Verkamp, Gresham T Richter, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 14, 2025
A comparison of JC virus assay performance provided with originator and biosimilar natalizumabJames Varley, Rahma Beyrouti, Richard Nicholas, et al.
Wellcome Open Research|December 21, 2016
Free serum haemoglobin is associated with brain atrophy in secondary progressive multiple sclerosisAlex Lewin, Shea Hamilton, Aviva Witkover, et al.
Acta Neuropathologica|March 23, 2010
Abnormal tau phosphorylation in primary progressive multiple sclerosisJane Marian Anderson, Rickie Patani, Richard Reynolds, et al.
British Journal of Clinical Pharmacology|May 7, 2022
Human pharmacokinetics of XBD173 and etifoxine distinguish their potential for pharmacodynamic effects mediated by translocator proteinDavid R Owen, Alexandra Phillips, Desmond O'Connor, et al.
Acta Neuropathologica|March 17, 2009
Evidence for abnormal tau phosphorylation in early aggressive multiple sclerosisJane Marian Anderson, Rickie Patani, Richard Reynolds, et al.
Annals of Neurology|December 27, 2023
High Levels of Perivascular Inflammation and Active Demyelinating Lesions at Time of Death Associated with Rapidly Progressive Multiple Sclerosis Disease Course: A Retrospective Postmortem Cohort StudyRichard Nicholas, Roberta Magliozzi, Damiano Marastoni, et al.
Brain : a Journal of Neurology|April 18, 2007
Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathologyRoberta Magliozzi, Owain Howell, Abhilash Vora, et al.
Pageof 17

Showing results (61-70 of 165) with videos related to

Sort By:
Pageof 17
Neurology|September 19, 2018
The utility of FDG-PET imaging in distinguishing PML-IRIS from PML in a patient treated with natalizumabAravindhan Baheerathan, Cillian McNamara, Sabrina Kalam, et al.
Orthopedics|October 3, 2014
Diabetic myonecrosis: likely an underrecognized entityMathew J Mazoch, Gitanjali Bajaj, Richard Nicholas, et al.
Pediatric Blood & Cancer|June 29, 2019
Effect of sirolimus on coagulopathy of slow-flow vascular malformationsJoana M Mack, Bethany Verkamp, Gresham T Richter, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 14, 2025
A comparison of JC virus assay performance provided with originator and biosimilar natalizumabJames Varley, Rahma Beyrouti, Richard Nicholas, et al.
Wellcome Open Research|December 21, 2016
Free serum haemoglobin is associated with brain atrophy in secondary progressive multiple sclerosisAlex Lewin, Shea Hamilton, Aviva Witkover, et al.
Acta Neuropathologica|March 23, 2010
Abnormal tau phosphorylation in primary progressive multiple sclerosisJane Marian Anderson, Rickie Patani, Richard Reynolds, et al.
British Journal of Clinical Pharmacology|May 7, 2022
Human pharmacokinetics of XBD173 and etifoxine distinguish their potential for pharmacodynamic effects mediated by translocator proteinDavid R Owen, Alexandra Phillips, Desmond O'Connor, et al.
Acta Neuropathologica|March 17, 2009
Evidence for abnormal tau phosphorylation in early aggressive multiple sclerosisJane Marian Anderson, Rickie Patani, Richard Reynolds, et al.
Annals of Neurology|December 27, 2023
High Levels of Perivascular Inflammation and Active Demyelinating Lesions at Time of Death Associated with Rapidly Progressive Multiple Sclerosis Disease Course: A Retrospective Postmortem Cohort StudyRichard Nicholas, Roberta Magliozzi, Damiano Marastoni, et al.
Brain : a Journal of Neurology|April 18, 2007
Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathologyRoberta Magliozzi, Owain Howell, Abhilash Vora, et al.
Pageof 17